Publicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (1)

2022

  1. Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies

    European Journal of Haematology, Vol. 109, Núm. 3, pp. 205-214